4 July 2019, story by Jacob Kushner, Anthony Langat, Qian Sun and Felix Franz

Counterfeit and substandard drugs are believed to kill thousands of people annually. The trade of substandard or falsified medicines has grown to a $30 billion black market industry. Experts warn that the number of counterfeit or substandard goods entering Africa is on the rise. This investigation reveals that in fact, Chinese malarial medicine Artemisinin may be doing far more good than harm in African nations like Kenya, where malaria is rampant. Rather, the diversion of free, public medicine into the black market where they are sold illegally in private pharmacies is an even larger barrier to getting East Africans the crucial, life-saving medicine they require.

The full article is on journalismfund.eu and posted on The Atlantic and DEVEX

Find the podcast here! 

Find more information in Deutsche Welle  (German) and The New Humanitarian